Study researchers assessed the morphometric and microstructural gray matter differences between primary progressive and relapsing remitting multiple sclerosis.
Study investigators used the visual pathway to assess the promyelinating and neuroprotective effects of alemtuzumab in multiple sclerosis.
Study researchers examined the different paradigms on the pathophysiology of MS, the outside-in and the inside-out theories.
Study researchers conducted a narrative review to update the public on the new classification of trigeminal neuralgia, clinical signs, pathophysiology, and management.
A team of investigators sought to determine whether κ- and λ-FLC index may predict early multiple sclerosis disease activity independent of demographics, clinical, and MRI characteristics.
Researchers called for effective tools for earlier identification of secondary progressive MS to improve long-term outcomes in patients with the disease.
This case study examines 2 patients with relapsing remitting multiple sclerosis, under dimethyl fumarate treatment, who developed severe herpes zoster infection.
Researchers advocate for implementing steroid therapy on an individual basis, not as routine.
Among patients with multiple sclerosis, those of older age and higher comorbidity burden are associated with the highest care consumption.
Certain ICD-10 codes are recorded more frequently before the initial diagnosis in patients with MS compared with patients with other autoimmune diseases.